Didier Jutras-Aswad
Centre hospitalier de l'Université de Montréal (CHUM) · Université de Montréal · CRCHUM
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
15
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
38
PubMed author-name match
Trials
Studies that name Didier Jutras-Aswad as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:50 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07811466 · Mobile Application-Based Interventions for Cannabis Use in Young Adults With First Episode PsychosisCentre hospitalier de l'Université de Montréal (CHUM) · not yet recruiting · First Episode Psychosis (FEP), Psychosis, Schizophreni-form Disorder · principal investigator
- N/ANCT07524985 · Joint Effort 2.0 : Evaluation Among General PopulationCentre hospitalier de l'Université de Montréal (CHUM) · recruiting · Cannabis Use · principal investigator
- N/ANCT07063589 · Cannabis Use Patterns Among Young Adults and Associations With Social and Health Outcomes.Centre hospitalier de l'Université de Montréal (CHUM) · recruiting · Cannabis Use · principal investigator
- Ph2NCT06788587 · Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use DisorderCentre hospitalier de l'Université de Montréal (CHUM) · recruiting · Methamphetamine Abuse, Methamphetamine-dependence, Addiction · principal investigator
- Ph1/Ph2NCT06099379 · Modulation of THC Effects by CBD: a Dose-ranging StudyCentre hospitalier de l'Université de Montréal (CHUM) · recruiting · Cannabis, THC · principal investigator
- Ph2NCT05854667 · Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA UsersCentre hospitalier de l'Université de Montréal (CHUM) · recruiting · Methamphetamine Abuse, Methamphetamine-dependence, Addiction, Substance · principal investigator
- N/ANCT05620433 · Joint Effort 2.0: a Mobile Application With University StudentsCentre hospitalier de l'Université de Montréal (CHUM) · completed · Cannabis Use, Cannabis, Cannabis Dependence · principal investigator
- Ph1/Ph2NCT05407285 · A Study of Ingested Cannabidiol in Healthy Occasional Cannabis UsersCentre hospitalier de l'Université de Montréal (CHUM) · completed · Cannabis · principal investigator
- Ph1/Ph2NCT05320367 · A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis UsersCentre hospitalier de l'Université de Montréal (CHUM) · not yet recruiting · Cannabis · principal investigator
- N/ANCT05310981 · A Cannabis E-intervention for Young Cannabis Users With Early Psychosis (iCC)Centre hospitalier de l'Université de Montréal (CHUM) · completed · Cannabis Use Disorder · principal investigator
- N/ANCT04968275 · A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early PsychosisCentre hospitalier de l'Université de Montréal (CHUM) · completed · Psychotic Disorder, Marijuana Use, Young Adult · principal investigator
- Ph4NCT03033732 · A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid MisuseDidier Jutras Aswad · completed · Opioid Use Disorder
- Ph2NCT02952196 · Cannabioids as a New Intervention for Amphetamine DependenceCentre hospitalier de l'Université de Montréal (CHUM) · withdrawn · Amphetamine Addiction · principal investigator
- Ph2NCT02559167 · Cannabidiol and Cocaine Craving/DependenceCentre hospitalier de l'Université de Montréal (CHUM) · completed · Substance Use Disorder, Cocaine Dependence, Withdrawal From Addictive Substance; Detoxification · principal investigator
- Ph4NCT02200406 · Desvenlafaxine in Opioid-Dependent PatientsCentre hospitalier de l'Université de Montréal (CHUM) · completed · Depression, Opioid Dependence, Methadone Treatment · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:50 UTC. The ranking covers the 200 most relevant of 38 PubMed records, and a shared surname and initials can bring in a namesake. All 38 on PubMed
- Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans.J Addict Med · 2015101 citationsRCR 4.8
- Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial.Addiction · 202157 citationsRCR 5.4
- Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.Am J Psychiatry · 202253 citationsRCR 6.6
- Specialized assertive community treatment intervention for homeless youth with first episode psychosis and substance use disorder: A 2-year follow-up study.Early Interv Psychiatry · 202028 citationsRCR 2.4
- 27 citationsRCR 3.2
- Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial.Pharmacol Biochem Behav · 202218 citationsRCR 2.3
- Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial.J Addict Med · 202216 citationsRCR 2.0
- Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial.Neuropsychopharmacology · 202115 citationsRCR 1.4
- Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.Can J Psychiatry · 202315 citationsRCR 2.9
- Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial.Drug Alcohol Depend · 202211 citationsRCR 1.4